# Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)

> **NCT01277822** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 334 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Losartan (+) amlodipine
- **DRUG:** Placebo to match losartan/amlodipine tablets
- **DRUG:** Amlodipine camsylate
- **DRUG:** Placebo to match amlodipine

## Key facts

- **NCT ID:** NCT01277822
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-30
- **Primary completion:** 2013-04-22
- **Final completion:** 2013-04-22
- **Target enrollment:** 334 (ACTUAL)
- **Last updated:** 2024-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01277822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01277822, "Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01277822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*